Unilife Corporation's (ASX: UNS, NASDAQ: UNIS) CDI's have been placed in pre-open today, following the ASX granting the company a trading halt pending an announcement regarding a 'commercial contract'.
Unilife is a developer and supplier of injectable drug delivery systems.
In April the company signed a 15-year customisation and commercial supply contract with a U.S. pharmaceutical company for the EZMix™ dual-chamber syringe, with the contract expected to generate up to $110 million.
The halt we last until the earlier of an announcement being made to the market, or the opening of trade on Wednesday 15th May 2013.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.